CFGS
LGND icon

Concourse Financial Group Securities’s Ligand Pharmaceuticals LGND Stock Holding History

Concourse Financial Group Securities’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72
Closed -$8.34K – 1195
2024
Q4 		$8.34K Hold
72
– – ﹤0.01% 1759
2024
Q3 		$7.21K Hold
72
– – ﹤0.01% 1773
2024
Q2 		$6.07K Hold
72
– – ﹤0.01% 1823
2024
Q1 		$5.26K Hold
72
– – ﹤0.01% 1871
2023
Q4 		$5.14K Hold
72
– – ﹤0.01% 1839
2023
Q3 		$4.31K Hold
72
– – ﹤0.01% 1851
2023
Q2 		$5.19K Sell
72
-15
-17% -$1.13K ﹤0.01% 1822
2023
Q1 		$6.4K Hold
87
– – ﹤0.01% 1802
2022
Q4 		$5.81K Sell
87
-52
-37% -$3.38K ﹤0.01% 1813
2022
Q3 		$7K Hold
139
– – ﹤0.01% 1570
2022
Q2 		$8K Hold
139
– – ﹤0.01% 1731
2022
Q1 		$10K Hold
139
– – ﹤0.01% 1689
2021
Q4 		$13K Hold
139
– – ﹤0.01% 1783
2021
Q3 		$12K Hold
139
– – ﹤0.01% 1836
2021
Q2 		$11K Hold
139
– – ﹤0.01% 1838
2021
Q1 		$13K Hold
139
– – ﹤0.01% 1692
2020
Q4 		$9K Hold
139
– – ﹤0.01% 1722
2020
Q3 		$8K Hold
139
– – ﹤0.01% 1652
2020
Q2 		$10K Sell
139
-223
-62% -$14.1K ﹤0.01% 1495
2020
Q1 		$16K Sell
362
-80
-18% -$4.53K ﹤0.01% 1321
2019
Q4 		$29K Buy
+442
New +$29.5K ﹤0.01% 1143
2019
Q3 		– Sell
-32
Closed -$2.01K – 1979
2019
Q2 		$2K Sell
32
-160
-83% -$11.8K ﹤0.01% 2005
2019
Q1 		$15K Sell
192
-45
-19% -$3.41K ﹤0.01% 1372
2018
Q4 		$20K Buy
237
+173
+270% +$18.4K ﹤0.01% 1150
2018
Q3 		$11K Buy
+64
New +$9.65K ﹤0.01% 1064

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concourse Financial Group Securities's LGND Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Ligand Pharmaceuticals (LGND) in Q1 2025, closing a stake of 72 shares — an estimated $8.34K sold.

Concourse Financial Group Securities first reported a position in LGND in Q3 2018 and held it in 25 quarters. The position peaked at $29K in Q4 2019. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Ligand Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 72 Ligand Pharmaceuticals shares in Q1 2025, an estimated $8.34K.
  • Concourse Financial Group Securities first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 25 quarters.
  • Concourse Financial Group Securities's Ligand Pharmaceuticals position peaked at $29K in Q4 2019.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.